Cited by 12Diabetes Management and ResearchNon-Invasive Vital Sign MonitoringDiabetes Management and Education

A Prototype of a New Noninvasive Device to Detect Nocturnal Hypoglycemia in Adolescents with Type 1 Diabetes—A Pilot Study

Schechter, Amir, Eyal, Ori, Zuckerman-Levin, Nehama, Amihai-Ben-Yaacov, Vered, Weintrob, Naomi, Shehadeh, Naim·2012·Diabetes Technology & Therapeutics

Abstract

Background: Severe hypoglycemic events are a major consequence of tight diabetes control. Continuous glucose monitoring systems (CGMSs) were recently introduced in order to minimize the risk of hypoglycemia. However, the present CGMSs are invasive and costly and have been recently demonstrated to be intolerant for most children and adolescents. Hence there is a need for a simple, noninvasive, convenient, and inexpensive device to detect hypoglycemic events. The Gili Medical Hypoglycemia Non Invasive Monitoring System (GMHNIMS) (Gili Medical Ltd., Migdal HaEmek, Israel) has been currently developed for these purposes. Subjects and Methods: Ten patients 14–18 years old with type 1 diabetes for at least 1 year participated in a pilot study that was held at the Meyer Children's Hospital, Rambam Medical Center, Haifa, Israel. All patients were either treated by insulin pump or by multiple daily injections. The GMHNIMS was connected to the study subjects during three consecutive nights in an inpatient setting while they received their usual insulin regimen. The system is composed of four sensors (heart rate, perspiration, skin temperature, and tremor) that detect physiologic changes during hypoglycemia. In addition, each patient was connected to a real-time CGMS for 3 nights. When a hypoglycemic event was suspected clinically by the patient, a bedside capillary glucose was checked by a glucometer. Results: The system was found to be convenient without any disturbances to sleep quality. The sensitivity of the GMHNIMS for detection of true hypoglycemic events was 100% with specificity of 85.7%. Conclusions: The new device showed high detection rates of nocturnal hypoglycemic events with an acceptable degree of false-positive readings. Being inexpensive and noninvasive, this device has the potential for routine use in insulin-treated patients.

Integrity signals

Registry

Crossref · 10.1089/dia.2012.0002

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schechter, A., Eyal, O., Zuckerman-Levin, N., Amihai-Ben-Yaacov, V., Weintrob, N., & Shehadeh, N.
Affiliations
  • Gili Medical Ltd.
  • Tel Aviv University (IL)
  • Rambam Medical Center
  • Technion – Israel Institute of Technology (IL)
Venue
Diabetes Technology & Therapeutics
Published
2012-08
Volume
14
Issue
8
Pages
683-689
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2055550325
Cited by
12
References
20
Citations by year
2026: 2 · 2025: 1 · 2022: 2 · 2020: 1 · 2019: 1 · 2018: 3 · 2015: 1 · 2013: 1
FWCI
0.51
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
nocturnal hypoglycemia, type 1 diabetes, adolescents, heart rate, sweating, skin temperature, tremor, continuous glucose monitoring, insulin pump therapy, multiple daily insulin injections, sleep quality, sensitivity and specificity
MeSH terms
Adolescent, Algorithms, Blood Glucose, Circadian Rhythm, Cost-Benefit Analysis, Diabetes Mellitus, Type 1, Equipment Design, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Israel, Male, Monitoring, Physiologic, Patient Compliance, Pilot Projects, Sensitivity and Specificity, Blood Glucose Self-Monitoring, Biosensing Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review